Acute coronary syndrome and khat herbal amphetamine use: An observational report

Circulation

Volumn 124, Issue 24, 2011, Pages 2681-2689

  Ali, Waleed M ^a   Al Habib, K F ^c   Al Motarreb, Ahmed ^f   Singh, Rajvir ^b   Hersi, Ahmad ^c   Al Faleh, Hussam ^d   Asaad, Nidal ^a   Al Saif, Shukri ^e   Almahmeed, Wael ^g   Sulaiman, Kadhim ^h   Amin, Haitham ⁱ   Al Lawati, Jawad ^j   Al Bustani, Nizar ^g   Al Sagheer, Norah Q ^k   Al Qahtani, Awad ^a   Al Suwaidi, Jassim ^l  

^a Departments of Cardiology   (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^d SECURITY FORCES HOSPITAL   (Saudi Arabia)

^e Saud Al Babtain Cardiac Hospital   (Saudi Arabia)

^f Sana's University   (Yemen)

^g SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^h ROYAL HOSPITAL   (Oman)

ⁱ BAHRAIN DEFENCE FORCE HOSPITAL   (Bahrain)

^j MINISTRY OF HEALTH   (Oman)

^k Al Thawra Hospital   (Yemen)

^l NONE

more..

Author keywords

acute coronary syndrome; adrenergic beta antagonists; cathinone; ethnicity; thrombolysis

Indexed keywords

AMPHETAMINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HERBACEOUS AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CATHA EDULIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY; DEATH; DISEASE CLASSIFICATION; DRUG USE; EDUCATION; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART RATE VARIABILITY; HOSPITAL ADMISSION; HUMAN; MALE; MEDICINAL PLANT; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE;

ACUTE CORONARY SYNDROME; ADULT; AGED; AMPHETAMINE; CATHA; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MIDDLE EAST; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PLANT PREPARATIONS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE;

EID: 83455213355     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.039768     Document Type: Article

References (53)

1. Mateen FJ, Cascino GD. Khat chewing: a smokeless gun? Mayo Clin Proc. 2010;85:971-973.
2. Corkery JM, Schifano F, Oyefeso S, Ghodse AH, Tonia T, Naidoo V, Button J. "Bundle of fun" or "bunch of problems"? Case series of khat-related deaths in the UK. Drugs: Education, Prevention, and Policy. September 7, 2010. http://informahealthcare.com/doi/full/10.3109/09687637.2010. 504200. Accessed December 10, 2010.
3. Bentur Y, Bloom-Krasik A, Raikhlin-Eisenkraft B. Illicit cathinone ("Hagigat") poisoning. Clin Toxicol (Phila). 2008;46:206-210.
4. Chappell JS, Lee MM. Cathinone preservation in khat evidence via drying. Forensic Sci Int. 2010;195:108-120.
5. Hansel J. Mayo Clinic studies Khat chewing. PostBulletin Journal. http://postbulletin.typepad.com/pulse-oN̈health/2010/11/mayo-clinic- studieskhat-chewing.html. Accessed November 3, 2010.
6. Schorno X, Steinegger E. CNS-active phenylpropylamines of Catha edulis FORSK: (Celastraceae) of Kenyan origin. Experientia. 1979;35:572-574. (Pubitemid 9224454)
7. Brenneisen R, Geisshüsler S. Psychotropic drugs, III: analytical and chemical aspects of Catha edulis Forsk. Pharm Acta Helv. 1985;60:290-301.
8. Kalix P. Cathinone, a natural amphetamine. Pharmacol Toxicol. 1992; 70:77-86.
9. Kalix P. The pharmacology of khat. Gen Pharmacol. 1985;15:179-187. (Pubitemid 14104069)
10. Murray CD, LeRoux CW, Emmanuel AV, Halket JM, Przyborowska AM, Kamm MA, Murray-Lyon IM. The effect of khat (Catha edulis) as an appetite suppressant is independent of ghrelin and PYY secretion. Appetite. 2008;51:747-750.
11. Ali WM, Zubaid M, Al-Motarreb A, Singh R, Al-Shereiqi SZ, Shehab A, Rashed W, Al-Sagheer NQ, Saleh AH, Al Suwaidi J. Association of khat chewing with increased risk of stroke and death in patients presenting with acute coronary syndrome. Mayo Clin Proc. 2010;85:974-980.
12. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, Granger CB, Ohman EM, Holmes DR. Prognostic implications of abnormalities in renal function in patients with cute coronary syndrome. Circulation. 2002;106:974-980. (Pubitemid 34925333)
13. AlHabib KF, Hersi A, Alsheikh-Ali AA, Sulaiman K, Alfaleh H, Alsaif S, Almahmeed W, Asaad N, Amin H, Al-Motarreb A, Al-Lawati J, Al Suwaidi J. Prevalence, predictors, and outcomes of conservative medical management in non-ST-segment elevation acute coronary syndromes in Gulf RACE-2: angiology. May, 11. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21561993. Accessed June 5, 2011.
14. Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue PY, Marcus GM. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010;170:874-879.
15. Dattilo PB, Hailpern SM, Fearon K, Sohal D, Nordin C. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51:117-125.
16. Gugelmann R, von Allmen M, Brenneisen R, Porzig H. Quantitative differences in the pharmacological effects of (r) and (f)-cathinone. Experientia. 1985;41:1568-1571.
17. Hassan NA, Gunaid AA, Khally FM, Al-Noami MY, Murray-Lyon IM. Khat chewing and arterial blood pressure: a randomized controlled clinical trial of alpha-1 and selective beta-adrenoceptor blockade. Saudi Med J. 2005;26:537-541. (Pubitemid 40711433)
18. Nencini P, Ahmed AM. Khat consumption: a pharmacological review. Drug Alcohol Depend. 1989;23:19-29. (Pubitemid 19054041)
19. Al-Motarreb A, Al-Kebsi M, Al-Adhi B, Broadley KJ. Khat chewing and acute myocardial infarction. Heart. 2002;87:279-280. (Pubitemid 34177691)
20. Toennes SW, Harder S, Schramm M, Niess C, Kauert GF. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br J Clin Pharmacol. 2003;56:125-130. (Pubitemid 36886498)
21. Al-Motarreb A, Broadley KJ. Coronary and aortic vasoconstriction by cathinone, the active constituent of khat. Auton Autocoid Pharmacol. 2004;23:319-326. (Pubitemid 39005672)
22. Baker KE, Herbert AA, Broadley KJ. Vasoconstriction of porcine left anterior descending coronary artery by ecstasy and cathinone is not an indirect sympathomimetic effect. Vasc Pharmacol. 2007;47:10-17. (Pubitemid 46818132)
23. Ragland AS, Ismail Y, Arsura EL. Myocardial infarction after amphetamine use. Am Heart J. 1993;125:247-249. (Pubitemid 23021655)
24. Packe GE, Garton MJ, Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J. 1990;64:23-24. (Pubitemid 20222210)
25. Wijetunga M, Bhan R, Lindsay J, Karch S. Acute coronary syndrome and crystal methamphetamine use: a case series. Hawaii Med J. 2004; 63:8-13, 25.
26. Turnipseed SD, Richards JR, Kirk JD, Diercks DB, Amsterdam EA. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med. 2003;24:369-373. (Pubitemid 36555556)
27. Bashour TT. Acute myocardial infarction resulting from amphetamine abuse: spasm-thrombus interplay? Am Heart J. 1994;128:1237-1239.
28. Lange RA, Cigarroa RG, Yancy CW Jr, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562. (Pubitemid 20008233)
29. Gebhard C, Breitenstein A, Akhmedov A, Gebhard CE, Camici GG, Lüscher TF, Tanner FC. Amphetamines induce endothelial tissue factor: role of dopamine receptor type 4. Eur Heart J. 2010;31:1780-1791.
30. Steffel J, Iseli S, Arnet C, Luscher TF, Tanner FC. Cocaine unbalances endothelial tissue factor and tissue factor pathway inhibitor expression. J Mol Cell Cardiol. 2006;40:746-749.
31. Haft JI, Kranz PD, Albert FJ, Fani K. Intravascular platelet aggregation in the heart induced by norepinephrine: microscopic studies. Circulation. 1972;46:698-708.
32. Broadley KJ. Autonomic Pharmacology. London, UK: Taylor & Francis; 1996.
33. Alkadi HO, Al-Kamarany M, Al-Kadi H, Lyoussi B, Khalil KA. Khataspirin interaction. Yemen J Pharm Biol Sci. 2008;2:32-39.
34. de Ridder S, Eerens F, Hofstra L. Khat rings twice: khat-induced thrombosis in two vascular territories. Neth Heart J. 2007;15:269-270. (Pubitemid 47502029)
35. Saha S, Dollery C. Severe ischemic cardiomyopathy associated with khat chewing. J R Soc Med. 2006;99:316-318. (Pubitemid 44013746)
36. Jones JH, Weir WB. Cocaine-induced chest pain. Clin Lab Med. 2006; 26:127-146.
37. Al-Motarreb A, Briancon S, Al-Jaber N, Al-Adhi B, Al-Jilani F, Salek MB, Broadley KJ. Khat chewing is a risk factor for acute myocardial infarction: a case-control study. Br J Clin Pharmacol. 2005;59:574-581. (Pubitemid 40632248)
38. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task Force on Beta-Blockers of the European Society of Cardiology. Expert consensus document on betaadrenergic receptor blockers. Eur Heart J. 2004;25:1341-1362.
39. McCord J, Jneid H, Hollander JE, de Lemos JA, Cercek B, Hsue P, Gibler WB, Ohman EM, Drew B, Philippides G, Newby LK. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117: 1897-1907. (Pubitemid 351507480)
40. Cornnor J, Makonnen E, Rostom A. Comparison of analgesic effects of khat (Catha edulis Forsk) extract, D-amphetamine and ibuprofen in mice. J Pharm Pharmacol. 2000;52:107-110. (Pubitemid 30125291)
41. Graziani M, Milella MS, Nencini P. Khat chewing from the pharmacological point of view: an update. Subst Use Misuse. 2008;43:762-783.
42. Yeo KK, Wijetunga M, Ito H, Efird JT, Tay K, Seto TB, Alimineti K, Kimata C, Schatz IJ. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med. 2007;120:165-171. (Pubitemid 46175764)
43. Maeno Y, Iwasa M, Inoue H, Koyama H, Matoba R, Nagao M. Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes. Forensic Sci Int. 2000;113:239-243. (Pubitemid 30654775)
44. He SY, Matoba R, Fujitani N, Koyama H, Matoba R, Nagao M. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol. 1996;17:155-116.
45. Vanwalleghem IE, Vanwalleghem PW, De Bleecker JL. Khat chewing can cause stroke. Cerebrovasc Dis. 2006;22:198-200. (Pubitemid 44114465)
46. Mujlli HM, Bo X, Zhang L. The effect of khat (Catha edulis) on acute cerebral infarction. Neurosciences. 2005;10:219-222. (Pubitemid 41059243)
47. Bruno A. Cerebrovascular complications of alcohol and sympathomimetic drug abuse. Curr Neurol Neurosci Rep. 2003;3:40-45. (Pubitemid 38898982)
48. Miranda J, O'Neill D. Stroke associated with amphetamine use. Ir Med J. 2002;95:281-282.
49. Hollander JE, Hoffman RS, Burstein JL, Shih RD, Thode HC Jr. Cocaineassociated myocardial infarction: mortality and complications: Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med. 1995; 155:1081-1086.
50. Bosch X, Loma-Osorio P, Guasch E, Nogué S, Ortiz JT, Sánchez M. Prevalence, clinical characteristics and risk of myocardial infarction in patients with cocaine-related chest pain. Rev Esp Cardiol. 2010;63: 1028-1034.
51. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010;363:905-917.
52. Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska H, Ramsey J, Lee T, Holt DW, Dargan PI. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol. 2010;6:327-330.
53. Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O, Davey Z, Corkery J, Siemann H, Scherbaum N, Farre' M, Torrens M, Demetrovics Z, Ghodse AH; Psychonaut Web Mapping; ReDNet Research Groups. Mephedrone (4-methylmethcathinone; "meow meow"): chemical, pharmacological and clinical issues. Psychopharmacology. 2011;214:593-602.